StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.68+0.13 (+0.96%)

Close on Nov 17, 2026Market cap $175.58MP/E –Yield –

MediWound revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $16.96M, down 16.1% from the year before. Over ten years it grew 39.7% a year on average. The highest annual figure on record is $31.79M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.96M-16.1%
FY2024Dec 31, 2024$20.22M+8.2%
FY2023Dec 31, 2023$18.69M-29.5%
FY2022Dec 31, 2022$26.50M+11.5%
FY2021Dec 31, 2021$23.76M+9.2%
FY2020Dec 31, 2020$21.76M-31.5%
FY2019Dec 31, 2019$31.79M+834.7%
FY2018Dec 31, 2018$3.40M+36.3%
FY2017Dec 31, 2017$2.50M+60.2%
FY2016Dec 31, 2016$1.56M+159.2%
FY2015Dec 31, 2015$601.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.09M-33.8%
Q2 FY2025Jun 30, 2025$5.71M-5.8%
Q2 FY2024Jun 30, 2024$5.06M+25.7%
Q2 FY2023Jun 30, 2023$4.77M-77.0%
Q2 FY2022Jun 30, 2022$4.67M+352.8%
Q2 FY2021Jun 30, 2021$6.06M+781.7%
Q2 FY2020Jun 30, 2020$4.03M–
Q2 FY2019Jun 30, 2019$20.75M–
Q2 FY2018Jun 30, 2018$1.03M–
Q2 FY2017Jun 30, 2017$687.00K–

More MediWound figures

See a number that looks wrong?